61 results
Page 2 of 4
8-K
EX-1.1
rv0dhcpugm 77q54
4 Mar 20
Entry into a Material Definitive Agreement
8:37am
8-K
EX-1.1
k0u9dp59jfm nz88
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
424B5
a6wiaj2
5 Dec 19
Prospectus supplement for primary offering
4:06pm
424B5
edzj ebi3ueshf8mr
4 Dec 19
Prospectus supplement for primary offering
4:12pm
8-K
EX-10.1
hxpm4d 3jf2ubok
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
8-K
EX-10.2
bjz3z8
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.3
lizyw42d6eup0
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.4
g7khefe2l2o8v9ajd6
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
DEFM14A
iy6spk yygn214
6 Nov 18
Proxy related to merger
12:00am
424B3
57l 97ilsuzzgy
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
mi0g1avjh2rs
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.45
njkj0lf888i4ayapod1h
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-10.1
tdyjdg2hm5 ty78854ij
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm